Income Statement
NEUROONE MEDICAL TECHNOLOGIES CORP
NMTC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
9.10 | 3.45 | 1.95 | 0.17 | 0.18 | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
|
Cost of Revenue
|
3.96 | 2.37 | 1.50 | 0.24 | 0.28 | - | - | - | - | - | - | - | 0.00 |
|
Gross Profit
|
5.14 | 1.08 | 0.46 | -0.07 | -0.10 | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
|
Operating Expenses
|
12.37 | 12.97 | 13.87 | 11.91 | 10.19 | 6.83 | 5.81 | 3.07 | 0.03 | 0.05 | 0.04 | 0.01 | 0.03 |
|
Research & Development
|
4.98 | 5.07 | 6.94 | 4.93 | 3.93 | 2.08 | 1.53 | 0.74 | - | - | - | - | - |
|
Selling, General & Administrative
|
7.38 | 7.90 | 6.93 | 6.98 | 6.26 | 4.75 | 4.28 | 2.34 | 0.03 | 0.05 | 0.04 | 0.01 | 0.03 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-7.23 | -11.89 | -13.41 | -11.98 | -10.28 | -6.83 | -5.81 | -3.07 | -0.03 | -0.05 | -0.04 | -0.01 | -0.03 |
|
Non-Operating Income
|
-3.62 | 0.43 | -1.55 | - | - | - | - | - | 0.00 | 0.01 | 0.00 | - | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | 0.26 | - | 0.01 | - | 0.00 | 0.00 |
|
Other Non-Op Income / Expense
|
- | 0.13 | 0.10 | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-3.61 | -12.32 | -11.86 | - | - | - | - | - | -0.03 | -0.06 | -0.04 | - | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | - | -0.27 | - | - | - | 0.02 | 0.00 | 0.00 | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-3.61 | -12.32 | -11.86 | -10.00 | -9.95 | -13.64 | -6.78 | -5.06 | -0.05 | -0.06 | -0.04 | -0.03 | -0.03 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-6.96 | -11.64 | -13.21 | -11.86 | -10.20 | -6.78 | -5.81 | -3.07 | -0.03 | -0.05 | -0.04 | -0.01 | -0.03 |
|
Earnings Per Share (Basic)
|
-0.09 | -0.46 | -0.65 | -0.63 | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.09 | -0.46 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
40.15 | 26.76 | 18.12 | 16.00 | - | - | - | - | - | - | - | 5.07 | 4.64 |
|
Diluted Weighted Avg Shares
|
40.15 | 26.76 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - |